No products in the cart.
| Description | TM30089 is a highly potent, selective CRTH2/DP2 antagonist. | ||
|---|---|---|---|
| Targets |
|
||
| In vitro | TM30089, which is structurally closely related to ramatroban, was found to bind mouse CRTH2 with nanomolar affinity and potently inhibit its signaling in cells overexpressing the receptor. In addition, TM30089 completely lacks affinity to the mouse TP receptor, unlike ramatroban which represents a dual TP/CRTH2 antagonist on both human and mouse receptor orthologs[1] | ||
| In vivo | Administration of TM30089 displayed anti-inflammatory efficacy in a mouse model of allergic asthma that mimics some of the major histopathological features characteristic of human asthma such as eosinophilia and mucus cell hyperplasia.[1] |
| Quantity | 1 grams, 5 grams |
|---|
Be the first to review “TM30089”
Related products
New Research Chemicals
$300.00 – $5,000.00
Powder for Hairloss Treatment Research
$25.00 – $75.00
Sale!
*Sales Promotion for 2022
$165.00 – $255.00
Powder for Hairloss Treatment Research
$100.00 – $350.00
Sale!
*New Arrival
$355.00 – $1,980.00
*New Arrival
$150.00 – $500.00
Sale!
*New Arrival
$50.00 – $700.00
Sale!
Powder for Hairloss Treatment Research
$99.00 – $159.00
Reviews
There are no reviews yet.